Business Description
Synlogic Inc
NAICS : 325412
SIC : 2834
ISIN : US87166L1008
Description
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.38 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.91 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -34.46 | |||||
| Beneish M-Score | 2.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 31.5 | |||||
| 3-Year EBITDA Growth Rate | 28.9 | |||||
| 3-Year EPS without NRI Growth Rate | 30.5 | |||||
| 3-Year FCF Growth Rate | 21.9 | |||||
| 3-Year Book Growth Rate | -53.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 71.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 128.01 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -46.12 | |||||
| 12-1 Month Momentum % | -65.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.82 | |||||
| Quick Ratio | 3.82 | |||||
| Cash Ratio | 3.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -53.4 | |||||
| Shareholder Yield % | -97.22 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1173.38 | |||||
| Net Margin % | -1771.74 | |||||
| FCF Margin % | -1557.45 | |||||
| ROE % | -165.05 | |||||
| ROA % | -100.73 | |||||
| ROIC % | -153.65 | |||||
| 3-Year ROIIC % | 256.62 | |||||
| ROC (Joel Greenblatt) % | -291.81 | |||||
| ROCE % | -125.9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.75 | |||||
| PB Ratio | 1.06 | |||||
| Price-to-Tangible-Book | 1.06 | |||||
| EV-to-EBIT | 0.05 | |||||
| EV-to-EBITDA | 0.06 | |||||
| EV-to-Revenue | -0.96 | |||||
| EV-to-Forward-Revenue | 45.64 | |||||
| EV-to-FCF | 0.06 | |||||
| Price-to-Net-Current-Asset-Value | 1.06 | |||||
| Price-to-Net-Cash | 1.19 | |||||
| Earnings Yield (Greenblatt) % | 2000 | |||||
| FCF Yield % | -289.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synlogic Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.914 | ||
| EPS (TTM) (€) | -2.408 | ||
| Beta | 0 | ||
| Volatility % | 59.76 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 3.75 | ||
| 12-1 Month Momentum % | -65.42 | ||
| 52-Week Range (€) | 3.329999 - 11.690999 | ||
| Shares Outstanding (Mil) | 9.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synlogic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synlogic Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Synlogic Inc Frequently Asked Questions
What is Synlogic Inc(FRA:MIN)'s stock price today?
The current price of FRA:MIN is €3.75. The 52 week high of FRA:MIN is €11.69 and 52 week low is €3.33.
When is next earnings date of Synlogic Inc(FRA:MIN)?
The next earnings date of Synlogic Inc(FRA:MIN) is 2024-11-08 Est..
Does Synlogic Inc(FRA:MIN) pay dividends? If so, how much?
Synlogic Inc(FRA:MIN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers